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SUPPLEMENTARY METHODS

Assay of dead cell numbers in 3D MSCs
3D spheroids initiated from 60,000 MSCs were collected at days 1, 3, 5. A sample at each time point was incubated with 70% ethanol for 45 minutes, then rinsed in PBS and incubated with 1µg/ml PI for 4 hours. These samples served as dead controls. For the test samples at each time point, samples were rinsed in PBS and incubated with 1µg/ml PI for 4 hours.
Samples were then isolated, snap frozen and sectioned. After sectioning, samples were stained with Hoechst 33342. Imaging was performed using the LSM510 confocal imaging system, all samples were imaged using identical imaging conditions.
Quantitative polymerase chain reaction (QPCR)
Gene Primer sequencesforward and reverse (5'-3')
GenBank accession number Table showing primer sequences used for quantitative polymerase chain reaction (QPCR).
Semi-solid expansion assay
For semi-solid expansion studies, MSCs were cultured as 60,000 cell spheroids for 5 days and disaggregated to small cell clumps as described above. Cell suspensions in DMEM, high glucose, were then mixed with semi-solid media (either medium 1: DMEM high glucose supplemented with 5% FBS and 1% methyl cellulose (final concentrations), or medium 2:
ESC medium supplemented with 1% methyl cellulose (final concentration)). MSCs were cultured at 37°C, 5% CO2 for 7 days. For RNA extraction, MSC aggregates were isolated by washing with PBS and then pelleted by centrifugation, before RNA extraction was performed using Trizol following manufacturer's instructions (Gibco). cDNA synthesis and QPCR was performed as described above.
Global gene expression analysis
For global gene expression analyses, duplicate RNA samples from two donors, maintained for 5 days in 2D or 3D culture were harvested as previously described. RNA quality was assessed using the Agilent 2100 Bioanalyzer with RNA 6000 nano chips and 150ng high quality RNA per sample (with RNA integrity numbers of 9.8 or greater), spiked with control RNA species from the Agilent One color spike-in kit, were Cy3-labelled using the Agilent One Color Low Input Quick Amp labeling kit. 600ng Cy3-labelled RNA per sample was then hybridized onto an Agilent SurePrint G3 Human Gene Expression 8x60K v2
Microarray and washed as per the manufacturer's guidelines. Arrays were scanned using an Agilent DNA Microarray Scanner (G2565CA) with SureScan High-Resolution
Technology. Data were analyzed using Genespring version 12.1 software (Agilent technologies), and all quality control checks met the standards required. This software was then used to draw clustered heatmaps of global expression data, and perform relevant statistical analyses. A paired sample t-test was employed, using the Benjamini -Hochberg algorithm to control for the effects of multiple testing. This procedure allowed for the adjustment of the p-values and the lowering of the false discovery rate whilst keeping the sensitivity for true positive results. Genes with a minimum two-fold difference in expression level and an adjusted p-value of <0.05 were considered differentially expressed. Subsequent pathway analysis was performed on lists of genes differentially expressed in response to change in culture conditions, using the pathway analysis tool within Genespring v12.1 software.
Ethical Approvals
The in vivo study was performed independently by Reinnervate Ltd (Co. Durham, UK).
Mouse ESCs (E14) included as positive controls were cultured and prepared by Reinnervate 
